Navigation Links
MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases
Date:12/16/2008

TIRAT CARMEL, Israel, December 16 /PRNewswire/ -- InSightec Ltd. announced today that cancer patients suffering pain caused by tumors that have spread to their bones have a new online resource for information about their condition. The website, http://www.MyCancerPain.org, provides background on bone metastases, as well as detailed information about a clinical trial being conducted at eleven centers in the U.S., Canada and Israel to evaluate whether treatment with the noninvasive, ionized radiation-free ExAblate(R) Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system can safely and effectively alleviate this pain.

"As modern oncology treatments have helped patients live longer with their disease, growing numbers of patients are living with the side effects of late-stage cancer, including bone pain," said Andre A. Konski, MD, MBA, MA, Director of Radiation Oncology Clinical Research and Chief Medical Officer at Fox Chase Cancer Center. "As physicians, our goal is not only to treat disease, but to help improve the quality of our patients' lives. We look forward to enrolling additional patients into this study in hopes of showing that this treatment may provide safe and effective pain relief for this condition. We encourage patients with bone metastases and their families to gather information on palliative treatments, including clinical trials such as this one, and discuss their options with their physicians."

Bone pain is the most common source of pain in patients suffering from metastatic cancer. Almost all patients with metastatic prostate cancer have skeletal metastases and 90% of patients with progressive breast cancer develop these painful and debilitating lesions.

Current pain treatments consist of systemic therapy (analgesics, chemotherapy, hormonal therapy and bisphosphonates) and local treatments (radiation, surgery and more recently, Radio Frequency Ablation (RFA)).

With ExAblate(R), the physician uses the Magnetic Resonance Imaging (MRI) with registered CT images to visualize the patient's anatomy and then aims focused ultrasound waves at the tumor to relieve the pain. The MRI allows the physician to monitor and continuously adjust the treatment in real time. The patient is consciously sedated to alleviate pain and minimize motion. Due to the high acoustic absorption and low thermal conductivity of the bone cortex, it is possible to use a low level of energy and still achieve a localized heating effect that will relieve the pain while minimizing damage to adjacent tissue.

Participating sites include Brigham & Women's Hospital in Boston, Fox Chase Cancer Center in Philadelphia, Houston Methodist in Houston, Texas, SightLine Medical Center, Houston, Texas, the Lahey Clinic in Burlington, Mass., the University of California, Los Angeles Medical Center in Los Angeles, Calif., the University of California, San Diego Medical Center in San Diego, Calif., Weill Cornell Medical College in New York, University Health Network in Toronto, and Sheba Medical Center in Tel Hashomer, Israel.

Additional information on the trial, including contact information for the clinical coordinators at each of the sites, can also be viewed at the National Institutes of Health's website, http://www.clinicaltrials.gov/ct2/show/NCT00656305?term=bone+metastases+insig htec&rank=1.

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

    Media Contact:
    Hollister Hovey
    Lazar Partners Ltd.
    hhovey@lazarpartners.com
    +1-212-867-1762


'/>"/>
SOURCE InSightec Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. National Drug Development Accelerator Launched
2. Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
3. Orange and Medic4all Launched the Worlds First Cellular Tele-Health Service
4. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
5. BioInnovation Institute in Akron Launched
6. Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease
7. Informex365.com is Launched for Manufacturers in Search of Chemical Reactions Expertise
8. GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
9. Partnering for Philanthropy Conference Launched to Unite Innovative Non-profit Research Organizations with Philanthropists and Industry
10. Augusta Systems Technologies Integrated into Ciscos Newly Launched Safety and Security Platform
11. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017   Sienna Biopharmaceuticals, Inc. , a privately ... that Richard Peterson will join the company ... Peterson, who brings more than two decades of global ... is retiring at the end of April but will ... joins Sienna from Novan, Inc., where he served as ...
(Date:3/23/2017)... BETHESDA, Md. , March 23, 2017 /PRNewswire/ ... company developing DCVax® personalized immune therapies for solid ... on the $7.5 million financing it announced last ... Company sold to several institutional investors securities totaling ... $.26 per share, and 10,000,000 shares of Class ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced ... the hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business ... joint development activities. , “Dr. Floyd’s career has spanned 30 years in the ...
Breaking Biology Technology:
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: AWRE), ... that Richard P. Moberg has resigned, effective ... and Chief Financial Officer and Treasurer of Aware citing ... serve as a member of the Board of Directors ... Aware,s co-Chief Executive Officer and co-President, General Counsel has ...
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):